EDT was doing well before the pandemic working on a blood cleaning machine for sepsis patients. Really cool innovation and the only one of its kind. Covid hit and crashed it along with every other stock around. But, they are helping out with the pandemic and they're going to rebound. Septic shock is happening to patients with Covid, so this is an opportunity for...
This stock has performed well over the past year, but recently saw a little slump. it trends up on longer time frames, despite it appearing to be a short play on the short time frames. The product they are trying to get out there is real, and sepsis is very real. Scrubbing your blood of it is something unique and needed in hospitals for severe cases. I predict...
